N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142275 |
| CAS No | NA |
| Mol.F. | C23H24I2N2O5 |
| Mol.Wt. | 662.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142276 |
| CAS No | NA |
| Mol.F. | C23H22I2N2O5 |
| Mol.Wt. | 660.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142277 |
| CAS No | NA |
| Mol.F. | C25H30N2O4 |
| Mol.Wt. | 422.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142278 |
| CAS No | NA |
| Mol.F. | C15H22N4O5S |
| Mol.Wt. | 370 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142279 |
| CAS No | NA |
| Mol.F. | C5H11N3O |
| Mol.Wt. | 129.16 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142280 |
| CAS No | NA |
| Mol.F. | C14H20N4O5S |
| Mol.Wt. | 356.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142281 |
| CAS No | NA |
| Mol.F. | C13H17IN4O3 |
| Mol.Wt. | 404.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142282 |
| CAS No | NA |
| Mol.F. | C16H24N4O5S |
| Mol.Wt. | 384.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142283 |
| CAS No | NA |
| Mol.F. | C14H20IN3O2 |
| Mol.Wt. | 389.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142284 |
| CAS No | NA |
| Mol.F. | C16H23N3O5S |
| Mol.Wt. | 369.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142285 |
| CAS No | NA |
| Mol.F. | C10H13N3O |
| Mol.Wt. | 191.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142286 |
| CAS No | NA |
| Mol.F. | C17H19N3O |
| Mol.Wt. | 281.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142287 |
| CAS No | NA |
| Mol.F. | C14H22N4O3 |
| Mol.Wt. | 294.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142288 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O2 |
| Mol.Wt. | 299.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142289 |
| CAS No | NA |
| Mol.F. | C11H15N3O3 |
| Mol.Wt. | 237.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142290 |
| CAS No | NA |
| Mol.F. | C18H17ClN4O2 |
| Mol.Wt. | 356.81 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |